166 related articles for article (PubMed ID: 33891517)
1. COVID-19 Toes and Other Skin Lesions During the Pandemic: Emerging Entities?
Vas PRJ; Georgiadis GS; Papanas N
Int J Low Extrem Wounds; 2022 Dec; 21(4):658-660. PubMed ID: 33891517
[TBL] [Abstract][Full Text] [Related]
2. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
Massey PR; Jones KM
Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
[TBL] [Abstract][Full Text] [Related]
3. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
[TBL] [Abstract][Full Text] [Related]
4. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
[TBL] [Abstract][Full Text] [Related]
5. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A
Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855
[TBL] [Abstract][Full Text] [Related]
6. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.
Colonna C; Genovese G; Monzani NA; Picca M; Boggio F; Gianotti R; Marzano AV
J Am Acad Dermatol; 2020 Sep; 83(3):965-969. PubMed ID: 32534082
[No Abstract] [Full Text] [Related]
7. Chilblain-like lesions with prominent bullae in a patient with COVID-19.
Rubin A; Alamgir M; Rubin J; Rao BK
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139373
[TBL] [Abstract][Full Text] [Related]
8. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
Hughes M; Rogers S; Lepri G; Bruni C; Matucci-Cerinic M
Br J Dermatol; 2020 Sep; 183(3):596-598. PubMed ID: 32460349
[No Abstract] [Full Text] [Related]
9. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
[TBL] [Abstract][Full Text] [Related]
10. COVID toes: Pernio-like lesions.
Burke KT; McGinnis KS; Petronic-Rosic V
Clin Dermatol; 2021; 39(3):380-383. PubMed ID: 34517996
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature.
Jindal R; Chauhan P; Goyal D; Shirazi N
Dermatol Ther; 2021 May; 34(3):e14951. PubMed ID: 33740317
[TBL] [Abstract][Full Text] [Related]
12. COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study.
Romita P; Maronese CA; DE Marco A; Balestri R; Belloni Fortina A; Brazzelli V; Colonna C; DI Lernia V; El Hachem M; Fabbrocini G; Foti C; Frasin LA; Guarneri C; Guerriero C; Guida S; Locatelli A; Neri I; Occella C; Offidani A; Oranges T; Pellacani G; Stinco G; Stingeni L; Barbagallo T; Campanati A; Cannavò SP; Caroppo F; Cavalli R; Costantini A; Cucchia R; Diociaiuti A; Filippeschi C; Francomano M; Giancristoforo S; Giuffrida R; Martina E; Monzani NA; Nappa P; Pastorino C; Patrizi A; Peccerillo F; Peris K; Recalcati S; Rizzoli L; Simonetti O; Vastarella M; Virdi A; Marzano AV; Bonamonte D
Ital J Dermatol Venerol; 2023 Apr; 158(2):117-123. PubMed ID: 37153946
[TBL] [Abstract][Full Text] [Related]
13. COVID toes: where do we stand with the current evidence?
Baeck M; Herman A
Int J Infect Dis; 2021 Jan; 102():53-55. PubMed ID: 33075530
[TBL] [Abstract][Full Text] [Related]
14. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
Yatim A; Gilliet M
Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic.
Sohier P; Matar S; Meritet JF; Laurent-Roussel S; Dupin N; Aractingi S
Arch Pathol Lab Med; 2021 Feb; 145(2):137-144. PubMed ID: 33501498
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak.
Gómez-Fernández C; López-Sundh AE; González-Vela C; Ocejo-Vinyals JG; Mayor-Ibarguren A; Salas-Venero CA; Gutiérrez-Larrañaga M; Tejerina-Puente A; Fariñas MC; Cabero-Pérez MJ; López-Hoyos M; González-López MA
Int J Dermatol; 2020 Dec; 59(12):1475-1484. PubMed ID: 33070314
[TBL] [Abstract][Full Text] [Related]
17. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2.
Ko CJ; Harigopal M; Damsky W; Gehlhausen JR; Bosenberg M; Patrignelli R; McNiff JM
J Cutan Pathol; 2020 Nov; 47(11):997-1002. PubMed ID: 32745281
[TBL] [Abstract][Full Text] [Related]
18. Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management.
Masood W; Ahmad S; Khan NA; Shakir A; Rokni GR; Gold MH; Cockerell CJ; Schwartz RA; Goldust M
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146777
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of COVID toes in outpatients: a case report.
Pouxe M; Abdulkarim A; de Vallière S; Seremet T; Favrat B; Kokkinakis I
J Med Case Rep; 2024 Jun; 18(1):307. PubMed ID: 38937799
[TBL] [Abstract][Full Text] [Related]
20. COVID toes or pernio?
Zaladonis A; Huang S; Hsu S
Clin Dermatol; 2020; 38(6):764-767. PubMed ID: 33341212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
